Engineers Gate Manager LP bought a new position in Bruker Corporation (NASDAQ:BRKR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 33,181 shares of the medical research company’s stock, valued at approximately $957,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Sheaff Brock Investment Advisors LLC purchased a new position in shares of Bruker Corporation in the 2nd quarter worth $237,000. Los Angeles Capital Management & Equity Research Inc. raised its position in shares of Bruker Corporation by 50.3% in the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 240,305 shares of the medical research company’s stock worth $6,930,000 after buying an additional 80,400 shares during the period. Eagle Asset Management Inc. raised its position in shares of Bruker Corporation by 18.3% in the 2nd quarter. Eagle Asset Management Inc. now owns 585,996 shares of the medical research company’s stock worth $16,900,000 after buying an additional 90,767 shares during the period. Scout Investments Inc. raised its position in shares of Bruker Corporation by 1.3% in the 2nd quarter. Scout Investments Inc. now owns 173,625 shares of the medical research company’s stock worth $5,007,000 after buying an additional 2,300 shares during the period. Finally, Keybank National Association OH raised its position in shares of Bruker Corporation by 4.1% in the 2nd quarter. Keybank National Association OH now owns 51,482 shares of the medical research company’s stock worth $1,485,000 after buying an additional 2,016 shares during the period. 65.42% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/15/engineers-gate-manager-lp-buys-shares-of-33181-bruker-corporation-brkr.html.

In related news, VP Mark Munch sold 21,061 shares of Bruker Corporation stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $29.97, for a total value of $631,198.17. Following the completion of the sale, the vice president now owns 60,524 shares of the company’s stock, valued at approximately $1,813,904.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Frank H. Laukien acquired 2,335 shares of Bruker Corporation stock in a transaction that occurred on Thursday, August 10th. The stock was acquired at an average cost of $27.39 per share, with a total value of $63,955.65. Following the purchase, the chief executive officer now owns 37,791,386 shares in the company, valued at approximately $1,035,106,062.54. The disclosure for this purchase can be found here. 35.20% of the stock is currently owned by insiders.

BRKR has been the topic of several research reports. Zacks Investment Research raised Bruker Corporation from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a research report on Thursday, July 6th. Wells Fargo & Company lowered Bruker Corporation from a “market perform” rating to an “underperform” rating in a research report on Wednesday, July 12th. Cowen and Company reaffirmed a “hold” rating and issued a $29.00 target price on shares of Bruker Corporation in a research report on Friday, July 14th. Barclays PLC reaffirmed an “equal weight” rating and issued a $30.00 target price (up from $26.00) on shares of Bruker Corporation in a research report on Monday, July 17th. Finally, BidaskClub lowered Bruker Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. One analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $27.00.

Shares of Bruker Corporation (NASDAQ:BRKR) opened at 30.08 on Friday. The company has a 50-day moving average price of $28.44 and a 200 day moving average price of $26.42. Bruker Corporation has a one year low of $19.59 and a one year high of $30.22. The firm has a market capitalization of $4.77 billion, a P/E ratio of 30.00 and a beta of 1.10.

Bruker Corporation (NASDAQ:BRKR) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.03. Bruker Corporation had a net margin of 9.65% and a return on equity of 26.66%. The business had revenue of $414.90 million during the quarter, compared to analyst estimates of $384.75 million. During the same quarter in the previous year, the business earned $0.20 EPS. Bruker Corporation’s quarterly revenue was up 11.6% compared to the same quarter last year. Analysts expect that Bruker Corporation will post $1.12 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Investors of record on Tuesday, September 5th will be paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.53%. The ex-dividend date is Thursday, August 31st. Bruker Corporation’s payout ratio is presently 16.00%.

Bruker Corporation Company Profile

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR).

Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.